TickerFacts.

A business in context

TEVA research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-18 · 0001193125-26-398105

  2. 4 · Ownership change

    Report date 2026-09-19 · 0001193125-26-397959

  3. 8-K · Current report

    Report date 2026-09-16 · 0001193125-26-393116 · Items 1.01,2.03,9.01

  4. 8-K · Current report

    Report date 2026-09-14 · 0001193125-26-390562 · Items 8.01

  5. 8-K · Current report

    Report date 2026-09-09 · 0001193125-26-389264 · Items 7.01,8.01,9.01

  6. 8-K · Current report

    Report date 2026-09-03 · 0001193125-26-381899 · Items 8.01,9.01

  7. 8-K · Current report

    Report date 2026-08-31 · 0001193125-26-381879 · Items 3.03,9.01

  8. 4 · Ownership change

    Report date 2026-08-21 · 0001193125-26-365116

  9. 4 · Ownership change

    Report date 2026-08-21 · 0001193125-26-365107

  10. 4 · Ownership change

    Report date 2026-08-17 · 0001193125-26-356853

  11. 4 · Ownership change

    Report date 2026-08-05 · 0001193125-26-341086

  12. 4 · Ownership change

    Report date 2026-08-03 · 0001193125-26-335026

  13. 4 · Ownership change

    Report date 2026-08-03 · 0001193125-26-335012

  14. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-323619

  15. 8-K · Current report

    Report date 2026-07-29 · 0001171843-26-004974 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-05-28 · 0001193125-26-245203 · Items 5.07

  17. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-191513

  18. 8-K · Current report

    Report date 2026-04-29 · 0001171843-26-002796 · Items 2.02,7.01,9.01

  19. DEF 14A · Proxy statement

    Report date 2026-05-28 · 0001193125-26-134756

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-034532

  21. 8-K · Current report

    Report date 2026-01-28 · 0001171843-26-000462 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2026-01-11 · 0001171843-26-000174 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-12-10 · 0001193125-25-316063 · Items 1.01,2.03,9.01

  24. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-266895

  25. 8-K · Current report

    Report date 2025-11-05 · 0001171843-25-007000 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001193125-25-169296

  27. 8-K · Current report

    Report date 2025-07-30 · 0001171843-25-004808 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-06-05 · 0001193125-25-135942 · Items 5.07

  29. 8-K · Current report

    Report date 2025-05-28 · 0001193125-25-129488 · Items 1.01,2.03,9.01

  30. 8-K · Current report

    Report date 2025-05-20 · 0001193125-25-125071 · Items 7.01,8.01,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001193125-25-114889

  32. 8-K · Current report

    Report date 2025-05-07 · 0001171843-25-002849 · Items 2.02,9.01

  33. DEF 14A · Proxy statement

    Report date 2025-06-05 · 0001193125-25-076829

  34. 10-K · Annual report

    Report date 2024-12-31 · 0001193125-25-020826

  35. 8-K · Current report

    Report date 2025-01-29 · 0001171843-25-000493 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2024-11-05 · 0001193125-24-256014 · Items 5.02

  37. SC 13G · Ownership disclosure

    0000315066-24-002849

  38. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001193125-24-252039

  39. 8-K · Current report

    Report date 2024-11-06 · 0001171843-24-006034 · Items 2.02,9.01

  40. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001193125-24-189924

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 0 transaction rows0AExercise / conversion: 8 transaction rows8MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

19 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-18
2026-09-22
Savage BrianS · Sale
Disposed
Ordinary Shares314.038.7
2026-09-18
2026-09-22
Savage BrianS · Sale
Disposed
Ordinary Shares2525.039.15
2026-09-18
2026-09-22
Savage BrianS · Sale
Disposed
Ordinary Shares4503.038.69
2026-09-18
2026-09-22
Savage BrianM · Exercise / conversion
Acquired
Ordinary Shares4503.034.7
2026-09-18
2026-09-22
Savage BrianM · Exercise / conversion
Disposed
Stock Options (right to buy)
Derivative security
4503.034.7
2026-09-18
2026-09-22
MIGNONE ROBERTOS · Sale
Disposed
Ordinary Shares367600.039.06
2026-08-21
2026-08-25
Weiss AmirM · Exercise / conversion
Acquired
Ordinary Shares2500.019.61
2026-08-21
2026-08-25
Weiss AmirS · Sale
Disposed
Ordinary Shares2500.037.63
2026-08-21
2026-08-25
Weiss AmirS · Sale
Disposed
Ordinary Shares6945.037.61
2026-08-21
2026-08-25
Weiss AmirM · Exercise / conversion
Disposed
Stock Options (right to buy)
Derivative security
2500.019.16
2026-08-21
2026-08-25
Satchi-Fainaro RonitS · Sale
Disposed
Ordinary Shares415.037.25
2026-08-17
2026-08-19
Lippman EvanS · Sale
Disposed
Ordinary Shares18600.036.57
2026-08-05
2026-08-10
Zaks Tal ZviS · Sale
Disposed
Ordinary Shares17.034.87
2026-08-03
2026-08-05
Jover PlacidS · Sale
Disposed
Ordinary Shares12827.034.88
2026-08-03
2026-08-05
Jover PlacidM · Exercise / conversion
Acquired
Ordinary Shares12827.0n/a
2026-08-03
2026-08-05
Jover PlacidM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
12827.00.0
2026-08-03
2026-08-05
Hughes Eric AM · Exercise / conversion
Acquired
Ordinary Shares52744.0n/a
2026-08-03
2026-08-05
Hughes Eric AS · Sale
Disposed
Ordinary Shares25578.034.88
2026-08-03
2026-08-05
Hughes Eric AM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
52744.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000818686TEVA PHARMACEUTICAL INDUSTRIES LTD
Teva Pharmaceuticals (Australia)Teva Pharmaceuticals (United States)Teva Pharmaceuticals (Ireland)Teva Pharmaceuticals (Hungary)Teva Pharmaceuticals (France)

Showing 5 of 5 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Teva Branded Pharmaceutical Products · alias · wikidata
  • Teva Branded Pharmaceutical Products R&D, Inc. · alias · wikidata
  • Teva Pharmaceuticals · alias · wikidata
  • Teva Pharmaceuticals (Australia) · subsidiary · wikidata
  • Teva Pharmaceuticals (United States) · subsidiary · wikidata
  • Teva Pharmaceuticals (Ireland) · subsidiary · wikidata
  • Teva Pharmaceuticals (Hungary) · subsidiary · wikidata
  • Teva Pharmaceuticals (France) · subsidiary · wikidata
  • TEVA PHARMACEUTICAL INDUSTRIES LIMITED · former SEC name · 1996-02-02 to 2001-01-16
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$16.54B$17.77B
2023-12-31$15.85B$17.52B
2022-12-31$14.93B$17.18B
2021-12-31$15.88B$19.74B
2020-12-31$16.66B$21.69B
2019-12-31$16.89B$22.25B
2018-12-31$18.27B$24.52B
2017-12-31$21.85B$30.04B

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗